Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

This publication has 15 references indexed in Scilit:

• Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
  New England Journal of Medicine, 2013
• Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome
  The Lancet, 2013
• Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)
  Clinical Infectious Diseases, 2013
• Seasonal Influenza A Virus in Feces of Hospitalized Adults
  Emerging Infectious Diseases, 2011
• Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection
  PLOS ONE, 2011
• Viral Clearance and Inflammatory Response Patterns in Adults Hospitalized for Pandemic 2009 Influenza A(H1N1) Virus Pneumonia
  Antiviral Therapy, 2010
• Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
  Nature Medicine, 2006
• Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
  Journal of Antimicrobial Chemotherapy, 2006
• Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma
  New England Journal of Medicine, 2005
• Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
  Virus Research, 2004